Beatrice A. Chen, MD, MPH
Associate Professor, Department of Obstetrics, Gynecology, & Reproductive Sciences
Dr Chen is a member of the Center for Family Planning Research, where researchers perform clinical research trials related to the development of new contraceptive methods and other techniques. The field of family planning addresses the needs of women and men by helping to control if and when they desire to become pregnant. By helping individuals avoid unintended pregnancies, women who become pregnant can do so at a time when they are able to best maximize the changes of a happy and healthy pregnancy. The goal of developing new contraceptive techniques is to find safer, easier to use and more effective ways to prevent pregnancies. Much of the research the Center does has a significant impact on the use and availability of contraceptives in developing countries. The Center works to find contraceptives that can also prevent the spread of sexually transmitted diseases, especially HIV.
Dr. Chen is also a member of the University of Pittsburgh’s Center for Women’s Health Research and Innovation and a member of the Reproductive Bridges Coalition with the goal of conducting research, providing education, and optimizing access to reproductive health services in Western Pennsylvania.
- Bell KN, Meyn LA, Chen BA. Long-acting reversible contraceptive uptake before and after the Affordable Care Act contraceptive mandate in women undergoing 1st trimester surgical abortion. Women’s Health Issues. 2018 Jul-Aug;28(4): 301-305.
- Rapkin RB, Achilles SL, Schwarz EB, Meyn L, Cremer M, Boraas CM, Chen BA. Self-administered vaginal lidocaine gel for intrauterine device insertion in nulliparous women: a randomized controlled trial. Obstet Gynecol. 2016 Sep;128(3):621-8.
- Boraas CM, Achilles SL, Cremer ML, Chappell CA, Lim SE, Chen BA. Synthetic osmotic dilators with adjunctive misoprostol for same-day dilation and evacuation: a randomized controlled trial. Contraception. 2016 Nov;94(5): 467-472.
- Whitaker AK and Chen BA. Society of Family Planning Clinical Guidelines: Postplacental insertion of intrauterine devices. Contraception 2018 Jan;97(1):2-13.
- Chen BA, Panther L, Marzinke MA, Hendrix CW, Hoesley CJ, van der Straten A, Husnik MJ, Soto-Torres L, Nel A, Johnson S, Richardson-Harman N, Rabe LK, Dezzutti CS. Phase 1 safety, pharmacokinetics, and pharmacodynamics of dapivirine and maraviroc vaginal rings: a double-blind randomized trial. JAIDS. 2015 Nov 1;70(3): 242-9.
- Chen BA, Reeves MF, Creinin MD, Schwarz EB. Postplacental or delayed levonorgestrel intrauterine device insertion and breastfeeding duration. Contraception Nov 2011; 84(5):499-504.
- Chen BA, Reeves MF, Hayes JL, Hohmann HL, Perriera LK, Creinin MD. Postplacental or delayed insertion of the levonorgestrel intrauterine device after vaginal delivery: a randomized controlled trial. Obstet Gynecol 2010; 116(5):79-87.
- Chen BA, Reeves MF, Creinin MD, Gilles JM, Barnhart K, Westhoff C, Zhang J. Misoprostol for treatment of early pregnancy failure in women with previous uterine surgery. Am J Obstet Gynecol June 2008; 198(6): 626.e1-626.e5.
For additional publications, please see PubMed Page.
For information on current trials at the Center for Family Planning Research, see the clinical trials section of Center’s site.